Lv1
40 积分 2024-06-14 加入
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature
10小时前
已完结
PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI
10小时前
已完结
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
11小时前
已完结
Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies
11小时前
已完结
Injection site reactions with the use of biological agents
1个月前
已完结
Treatment of psoriasis with biological agents: a Chinese expert consensus statement （2019）
2个月前
已完结
Methods for Imputing Missing Efficacy Data in Clinical Trials of Biologic Psoriasis Therapies: Implications for Interpretations of Trial Results
2个月前
已关闭
Disease modification in inflammatory skin disorders: opportunities and challenges
2个月前
已完结
Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience
2个月前
已完结
Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients
2个月前
已关闭
皖公网安备34019202002308
